1. Home
  2. TBLA vs ATRC Comparison

TBLA vs ATRC Comparison

Compare TBLA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$5.57

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$34.15

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
ATRC
Founded
2007
2000
Country
United States
United States
Employees
2000
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TBLA
ATRC
Price
$5.57
$34.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$5.00
$51.17
AVG Volume (30 Days)
3.9M
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.74
EPS
N/A
N/A
Revenue
N/A
$201,630,000.00
Revenue This Year
$7.63
$15.27
Revenue Next Year
$5.25
$12.21
P/E Ratio
$42.36
N/A
Revenue Growth
N/A
15.40
52 Week Low
$2.84
$25.36
52 Week High
$5.71
$43.18

Technical Indicators

Market Signals
Indicator
TBLA
ATRC
Relative Strength Index (RSI) 66.56 70.23
Support Level $3.86 $34.16
Resistance Level N/A $34.38
Average True Range (ATR) 0.24 1.50
MACD 0.07 0.62
Stochastic Oscillator 89.02 91.94

Price Performance

Historical Comparison
TBLA
ATRC

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: